🇺🇸 FDA

Company profile · Sponsor

China

China SXT Pharmaceuticals

SXTC · NYSE pharma TAIZHOU, USA
Pipeline
24
Drugs
0
Patents
8

Quick answer

China (SXTC) is a pharma company. headquartered in TAIZHOU, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker SXTC
Exchange NYSE
Company type pharma
Headquarters TAIZHOU, USA
SEC CIK 0001723980

Pipeline (24)

Search pipeline →

  1. 2mg Baricitinib

    China

    Acute Ichemic Stroke

    phase 3 small molecule active

    1 trial

  2. 5% Lidocaine patch

    China

    Herpes Zoster Pain

    phase 3 small molecule completed

    1 trial

  3. 5% cysteamine cream

    China

    Melasma

    phase 3 other completed

    1 trial

  4. 5-Fu/epirubicin/CTX following Docetaxel

    China

    Breast Cancer

    phase 3 small molecule active

    1 trial

  5. 68Ga-PSMA-11

    China

    Biochemical Recurrence of Malignant Neoplasm of Prostate

    phase 3 small molecule active

    1 trial

  6. ATLG

    China

    Hematopoietic Stem Cell Transplantation

    phase 3 small molecule active

    1 trial

  7. Adjuvant chemotherapy

    China

    Total Neoadjuvant Treatment

    phase 3 small molecule active

    1 trial

  8. Adjuvant immunotherapy

    China

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  9. Almonertinib

    China

    Non-small Cell Lung Cancer Metastatic

    phase 3 small molecule active

    1 trial

  10. Amlodipine

    China

    Essential Hypertension

    phase 3 small molecule active

    1 trial

  11. Anterior Capsulotomy

    China

    Obsessive-Compulsive Disorder

    phase 3 other active

    1 trial

  12. Anti-PD-1 antibody drug named Serplulimab

    China

    Locally Advanced Rectal Cancer (LARC)

    phase 3 small molecule active

    1 trial

  13. Astragalus Membranaceus

    China

    Aneurysmal Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

  14. Atropine sulfate eye drops 0.01%

    China

    Myopia

    phase 3 small molecule active

    1 trial

  15. Bilateral Nucleus Accumbens DBS (Suzhou Sceneray)

    China

    Obsessive Compulsive Disorder

    phase 3 other terminated

    1 trial

  16. Bisoprolol Fumarate

    China

    Duchenne Muscular Dystrophy

    phase 3 small molecule active

    1 trial

  17. Brentuximab Vedotin for Injection

    China

    Classical Hodgkin Lymphoma

    phase 3 small molecule active

    1 trial

  18. Buprenorphine Transdermal System

    China

    Disease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)

    phase 3 small molecule completed

    1 trial

  19. Butylphthalide

    China

    Restenosis

    phase 3 small molecule completed

    1 trial

  20. Capecitabine

    China

    Nasopharyngeal Carcinoma

    phase 3 small molecule active

    1 trial

  21. Capox chemotherapy

    China

    Rectal Cancer

    phase 3 small molecule active

    1 trial

  22. Cardioblate® Surgical Ablation System

    China

    Rheumatic Valve Disease

    phase 3 other active

    1 trial

  23. Chickenpox Vaccines

    China

    Chickenpox Vaccines

    phase 3 mab completed

    1 trial

  24. Cisplatin

    China

    Nasopharyngeal Carcinoma

    phase 3 small molecule completed

    1 trial

Patents (8)

Search patents →

  1. US 12427137

    Method for reducing methane production in animal stomach

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12421269

    SGLT2/DPP4 inhibitor and application thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12403167

    Phenylethanoid glycoside extract from Acanthus ilicifolius L., preparation method thereof and use as anti-liver injury medicament

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12397034

    Pharmaceutical composition for promoting neurogenesis and method for promoting neurogenesis and inhibiting senescence of brain neurons

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12389931

    Oyster peptide with effect of improving sexual function and preparation method thereof

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12383535

    Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12378241

    Pyridine derivative as FGFR and VEGFR dual inhibitors

    Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12371434

    MLL1 inhibitors and anti-cancer agents

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is China?

China (SXTC) is a pharma company. headquartered in TAIZHOU, USA. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does China sponsor?

We track 24 ClinicalTrials.gov-linked programs for China, including 2mg Baricitinib and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does China company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.